Exagen Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $6.22 on 12/16/24, while the lowest price for the same period was registered at $1.30 on 04/16/24.
52-week price history of XGN Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Exagen Inc’s current trading price is -19.29% away from its 52-week high, while its distance from the 52-week low is 286.06%. The stock’s price range during this period has spanned from $1.30 to $6.22. In the Healthcare sector, the Exagen Inc’s shares surpassed a trading volume of approximately 1.1 million for the day, which was noticeably higher compared to the average daily volume of 9.0.15 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Exagen Inc (XGN) has experienced a quarterly rise of 106.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 88.54M and boasts a workforce of 179 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.54, with a change in price of +2.07. Similarly, Exagen Inc recorded 111,670 in trading volume during the last 100 days, posting a change of +70.17%.
Examining XGN’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for XGN stands at 1.83. Similarly, the long-term debt-to-equity ratio is also 1.69.
XGN Stock Stochastic Average
Today, Exagen Inc’s raw stochastic average for the past 50 days stands at 65.32%, indicating a decline from the raw stochastic average of the last 20 days, which was 87.26%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 81.19% and 77.76% respectively.
XGN Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 22.44%. However, over the past six months, we’ve seen a weaker performance of 146.08%. The price of XGN fallen by 62.46% over the last 30 days. And in the last five days, it has surged by 23.65%.
